Phospholipid biosynthetic enzymes in human brain

Area of Science:

• Neurochemistry
• Molecular Neuroscience
• Biochemistry

Background:

• Brain membrane phospholipid metabolism is implicated in neurodegenerative and psychiatric disorders.
• Drugs targeting neural membrane synthesis, like CDPcholine, are used, but their specific enzyme targets in the human brain are unknown.
• Understanding these enzymes is crucial for developing targeted therapies.

Purpose of the Study:

• To characterize human brain enzymes involved in phosphatidylethanolamine (PE) and phosphatidylcholine (PC) synthesis.
• To compare the substrate affinities of enzymes in PE versus PC synthesis pathways.
• To investigate potential differences in the regulation of PE and PC synthesis.

Main Methods:

• Analysis of enzyme kinetics and substrate affinities using human brain biopsies.
• Measurement of enzyme inhibition by related substrates and products.
• Fractionation of enzymes into cytosolic and particulate components.

Main Results:

• Human brain ethanolamine kinase has a significantly lower affinity for ethanolamine (Km = 460 microM) compared to choline kinase for choline (Km = 17 microM).
• Ethanolamine kinase is inhibited by choline and phosphocholine, while choline kinase is largely unaffected by ethanolamine or phosphoethanolamine.
• Phosphoethanolamine cytidylyltransferase (PECT) is cytosolic, and phosphocholine cytidylyltransferase (PCCT) is particulate; both show low affinity for CTP.

Conclusions:

• Distinct regulatory properties exist for PE and PC synthesis in the human brain.
• The rate of PE synthesis may be more sensitive to ethanolamine availability than PC synthesis is to choline availability.
• Enzyme activities, particularly cytidylyltransferases, are likely highly dependent on cellular CTP concentrations.